Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Class A Ordinary Shares, par value $0.0001 per share
-
Shares outstanding
-
73,766,892
-
Total 13F shares
-
42,890,401
-
Share change
-
+906,765
-
Total reported value
-
$107,244,382
-
Put/Call ratio
-
55%
-
Price per share
-
$2.50
-
Number of holders
-
87
-
Value change
-
-$472,426
-
Number of buys
-
50
-
Number of sells
-
24
Institutional Holders of Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (ZURA) as of Q4 2024
As of 31 Dec 2024,
Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (ZURA) was held by
87 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,890,401 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, Deep Track Capital, LP, RA CAPITAL MANAGEMENT, L.P., GREAT POINT PARTNERS LLC, Pfizer Inc, BlackRock, Inc., JPMORGAN CHASE & CO, BRAIDWELL LP, Point72 Asset Management, L.P., and ADAR1 Capital Management, LLC.
This page lists
87
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.